CBRX($0.92) - FDA ruling is expected on Feb 26th. It will most likely not be approved since the Advisory Panel recommended against approving it: http://finance.yahoo.com/news/FDA-Advisory-Committee-prnews-2167578464.html?x=0 Panel vote was 13 No; 4 yes - Something to keep in mind if you are trading.